VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
BRKR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
BRKRBruker Corporation
$59.71$9.1B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksBRKRBalance Sheet

Bruker Corporation (BRKR) Balance Sheet

27Y historyFree accessUpdated daily

The company's reliance on debt to fund expansion is reflected in a debt-to-equity ratio of 0.81 as of 2025Q4, with $1.5 billion in goodwill now representing a substantial portion of total assets.

BRKR Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99
Total Current Assets2.1B2.21B2.05B2.16B2.11B2.47B1.93B1.8B1.3B1.36B1.27B1.23B1.37B1.43B1.31B1.19B1.05B873.5M820.7M395.63M294.74M265.61M271.29M250.63M145.47M138.92M147.42M41.52M
Cash & Short-Term Investments133.4M298.8M183.4M488.3M645.5M1.17B731.8M684.9M322.4M439.2M500.3M468.3M497.5M438.7M310.6M246M230.4M207.1M167.7M72.88M52.15M99.58M77.69M76.84M46.91M70.13M94.63M2.44M
Cash Only133.4M298.8M183.4M488.3M645.5M1.07B681.8M678.3M322.4M325M342.4M267.1M319.5M438.7M310.6M246M230.4M207.1M166.2M72.88M52.15M53.16M32.55M62.64M32.16M8.38M21.73M2.44M
Short-Term Investments00000100M50M6.6M0114.2M157.9M201.2M178M000001.5M0046.42M45.14M14.2M14.75M61.75M72.89M0
Accounts Receivable542.7M736M701.2M621.8M595.3M416.9M335.3M362.2M357.2M319.3M243.9M234.7M293.2M307.6M289.3M282.8M232.9M184.1M171.9M122.14M88.63M53.74M67.32M54.69M27.18M16.2M11.63M12.2M
Days Sales Outstanding73.4678.1776.0376.5685.8662.9361.5863.7968.786655.2552.7659.1661.0458.9562.4965.1560.2956.6781.4274.2365.9286.476.5885.2663.855.468.86
Inventory1.12B1.09B1.07B968.3M800.1M710.1M692.3M577.2M509.6M486.2M440.4M422M477.4M589.8M611.5M576.2M511M422.8M425.1M171.33M134.5M96.33M107.75M110.05M67.71M47.53M36.78M25.44M
Days Inventory Outstanding223.33214.94227.01243.54238.4214.51241.19195.56186.83186.23185.02168.3166.65208.16232.5233.89266.87258.97257.7212.39207.59204.71237277.35442.31398.02377.24330.11
Other Current Assets306M47.9M39.6M30.3M29M176.6M165.6M172M115.1M114.1M91.3M106.5M98.2M95.8M98.3M89.1M76.8M59.5M56M36.48M19.46M15.95M18.53M9.05M3.67M5.06M4.39M1.43M
Total Non-Current Assets4.03B4.03B3.75B2.09B1.5B1.18B1.12B975.2M824.3M589.7M540.1M499.3M498.5M556.4M546.7M516.4M498.7M298.5M295.6M157.58M138.44M95.28M100.26M100.41M57.63M50.15M37.13M25.79M
Property, Plant & Equipment719.6M910.6M814.8M691.4M538.2M466M462.9M371.7M270.6M266.5M239.1M231.1M249.9M299.5M283.6M249M233.7M223.4M221.3M103.1M90.35M72.34M84.99M81.35M52.54M37.25M25.53M25.35M
Fixed Asset Turnover4.41x3.77x4.13x4.29x4.70x5.19x4.29x5.58x7.01x6.63x6.74x7.03x7.24x6.14x6.32x6.63x5.58x4.99x5.00x5.31x4.82x4.11x3.35x3.20x2.21x2.49x3.00x2.55x
Goodwill01.55B1.51B582.6M457.6M339.5M320.4M293M275.7M169.8M130.6M130.6M127.8M127.4M115.9M100.2M98.3M47.5M46.4M40.78M39.78M17.52M10.74M00000
Intangible Assets0899.6M912.5M330.5M270.9M211.8M229.1M233.2M218.7M82.4M69.7M74.7M83.8M105.6M117M136.4M136.1M4.9M6M4.13M5.58M1.53M1.43M12.64M3.41M1.59M2.33M438.2K
Long-Term Investments16.1M8.2M000000-59.3M-71M-93.1M-62.9M-37M-23.9M-30.2M-30.8M-30.6M-22.7M0000001.68M11.3M00
Other Non-Current Assets3.31B241.1M232.7M184M155.1M70.8M39.6M16.8M8.4M14M16.6M9.9M7.3M5.2M12.6M13.6M18.1M9.3M21.9M9.57M2.74M3.89M3.1M6.41M-7.48M-7.72M9.27M0
Total Assets6.13B6.24B5.81B4.25B3.61B3.65B3.05B2.77B2.13B1.95B1.81B1.73B1.86B1.99B1.86B1.71B1.55B1.17B1.12B553.21M433.19M360.89M371.55M351.03M203.1M189.07M184.55M67.31M
Asset Turnover0.55x0.55x0.58x0.70x0.70x0.66x0.65x0.75x0.89x0.91x0.89x0.94x0.97x0.93x0.96x0.97x0.84x0.95x0.99x0.99x1.01x0.82x0.77x0.74x0.57x0.49x0.42x0.96x
Asset Growth %23.49%7.49%36.63%17.67%-1.05%19.71%10.01%30.2%9.24%7.48%4.74%-7.18%-6.21%7.11%8.53%10.37%32.24%4.99%101.78%27.71%20.03%-2.87%5.84%72.83%7.42%2.45%174.19%-
Total Current Liabilities1.36B1.28B1.28B1.2B914.3M938.5M791.9M645.6M598M524.5M525.9M554.6M582.7M648.6M681.9M755.8M831.5M539.1M519.7M252.95M195.13M111.53M111.16M108.6M58.18M39.32M36.37M29.44M
Accounts Payable269.1M215.9M234.1M202.7M178.4M147.4M134.6M118.4M104.5M90.8M86.1M72.1M76M74.8M69.6M72.3M64M49.8M43.3M32.58M23.1M17.21M22.65M22.52M20.66M9.87M7.6M6.66M
Days Payables Outstanding4442.3949.7750.9853.1644.5346.8940.1238.3134.7836.1728.7526.5326.426.4629.3533.4230.526.2540.3935.6536.5749.8356.75134.9482.6777.9686.43
Short-Term Debt8.4M51.8M32.5M121.2M18.7M112.4M2.2M500K18.5M020.1M600K800K700K1.3M83.7M214.4M22M41M31.72M21.86M9.56M12.21M18.59M18.41M3.88M02.5M
Deferred Revenue (Current)1.4B441.3M438.2M400M370.2M335.9M307.2M240.5M124.4M111.7M149M178.3M189.5M258.6M267.3M351.6M242.2M219.2M44.7M24.42M49.46M29.23M21.05M23.19M18.24M14.88M00
Other Current Liabilities597.9M302.8M300.3M218.3M159.9M156.4M121.3M119.5M288.5M256.3M269.8M306.8M340M400.2M375.5M94.9M84.8M249.2M49.2M114.8M56.69M47.84M30.2M44.3M11.08M20.44M23.23M20.28M
Current Ratio1.55x1.73x1.60x1.80x2.31x2.63x2.43x2.78x2.18x2.59x2.42x2.22x2.34x2.21x1.92x1.58x1.26x1.62x1.58x1.56x1.51x2.38x2.44x2.31x2.50x3.53x4.05x1.41x
Quick Ratio0.72x0.87x0.77x0.99x1.44x1.88x1.56x1.89x1.33x1.66x1.58x1.46x1.53x1.30x1.02x0.82x0.65x0.84x0.76x0.89x0.82x1.52x1.47x1.29x1.34x2.32x3.04x0.55x
Cash Conversion Cycle252.78250.72253.27269.12271.1232.91255.87219.23217.29217.45204.1192.3199.28242.8264.98267.04298.59288.76288.13253.41246.16234.06273.57297.17392.63379.16354.67312.53
Total Non-Current Liabilities2.27B2.45B2.71B1.63B1.57B1.63B1.28B1.19B625.5M690.5M593.9M443.4M510.4M489.5M464.9M329.8M190.9M214.1M283.9M41.06M46.35M41.33M42.92M39.88M18.54M22.2M24.02M27.81M
Long-Term Debt1.66B1.69B2.06B1.16B1.2B1.22B842.3M812.8M322.6M415.6M391.6M265.2M354.2M354.3M335.9M219.4M86.6M115.7M182.8M6.39M22.86M25.07M27.76M26.37M8.04M11.32M12.04M12.84M
Capital Lease Obligations296.6M296.6M118.9M74.8M34.8M41.8M47M47M7.1M1.3M00000001.1M0000000000
Deferred Tax Liabilities112.5M112.5M118.5M67.7M62.3M46M43.1M48.8M51.1M24.3M10.1M9.5M17.8M22.6M12.1M23.8M18.8M25.2M-35.4M000007.48M7.72M7.47M8.79M
Other Non-Current Liabilities609.9M239.2M311M240.2M166.5M266.9M299.5M236.3M182.5M200.6M145.4M123.5M101.3M78.9M82M53.9M56.2M39.1M65.7M34.67M23.49M16.25M15.16M13.51M9.26M10.21M4.5M6.18M
Total Liabilities3.63B3.73B3.99B2.84B2.48B2.57B2.07B1.83B1.22B1.22B1.12B998M1.09B1.14B1.15B1.09B1.02B753.2M803.6M294.02M241.48M152.85M154.08M148.48M76.72M61.53M60.38M57.25M
Total Debt1.67B2.04B2.25B1.38B1.27B1.39B912.8M880.9M341.1M415.6M411.7M266.7M355M355M337.2M303.1M301M137.7M223.8M38.11M44.72M29.43M39.97M44.96M23.39M15.21M12.04M15.34M
Net Debt1.54B1.74B2.06B891.3M624.9M325.7M231M202.6M18.7M90.6M69.3M-400K35.5M-83.7M26.6M57.1M70.6M-69.4M57.6M-34.77M-7.43M-23.73M7.42M-17.68M-8.77M6.83M-9.7M12.9M
Debt / Equity0.67x0.81x1.24x0.98x1.12x1.28x0.94x0.94x0.37x0.56x0.59x0.36x0.46x0.42x0.48x0.48x0.57x0.33x0.72x0.15x0.23x0.14x0.18x0.22x0.19x0.12x0.10x1.53x
Debt / EBITDA4.21x4.48x5.14x2.50x2.44x2.77x2.78x2.34x1.04x1.49x1.78x1.34x2.15x1.69x1.57x1.91x1.86x0.83x1.62x0.61x1.02x1.53x4.61x6.25x1.68x1.63x2.47x2.30x
Net Debt / EBITDA3.87x3.82x4.72x1.62x1.20x0.65x0.70x0.54x0.06x0.33x0.30x-0.00x0.22x-0.40x0.12x0.36x0.44x-0.42x0.42x-0.56x-0.17x-1.23x0.86x-2.46x-0.63x0.73x-1.99x1.94x
Interest Coverage1.14x1.36x5.32x34.18x26.71x28.52x16.68x18.53x21.84x15.30x15.74x14.05x19.10x13.27x10.67x20.93x27.80x18.21x2.59x4.26x9.18x--0.71x-1.52x0.28x--2.36x
Total Equity2.5B2.51B1.82B1.41B1.13B1.08B974.3M938.2M913.6M741.6M699.8M739.7M777.5M854.3M709.7M628.3M530.1M420.4M312.7M259.2M191.71M208.03M217.47M202.55M126.38M127.55M124.17M10.06M
Equity Growth %111.04%38.29%28.44%24.87%4.33%11.34%3.85%2.69%23.19%5.97%-5.39%-4.86%-8.99%20.37%12.96%18.52%26.09%34.44%20.64%35.21%-7.85%-4.34%7.37%60.27%-0.92%2.72%1134.6%-
Book Value per Share16.3916.5412.149.607.587.096.305.995.814.664.314.374.595.074.243.763.202.551.891.581.872.062.261.962.402.362.210.22
Total Shareholders' Equity2.47B2.46B1.78B1.38B1.11B1.07B961.2M906.8M905.1M733.5M693.1M732.9M771.7M850.2M706.6M624.9M527.4M418.8M311.9M258.66M191.47M207.8M217.28M202.43M126.38M127.55M124.17M10.06M
Common Stock01.8M1.8M1.7M1.7M1.7M1.7M1.7M1.7M1.7M1.7M1.7M1.7M1.7M1.7M1.7M1.6M1.6M1.6M1.05M1.02M898K895K865K550K549K548K455K
Retained Earnings02.36B2.41B2.32B1.93B1.66B1.41B1.27B1.1B942M885.2M757.4M655.8M599.1M519M441.5M349.2M253.8M172.6M48.24M17.47M-18.54M-22.19M-14.36M6.1M12.3M8.66M6.41M
Treasury Stock0-1.24B-1.24B-1.24B-1.08B-820.3M-667M-543.8M-401.5M-401.2M-249.3M-90.9M-900K-600K-200K-200K-200K-100K-100K0000-2.33M-3.09M000
Accumulated OCI0-79.5M-103.5M6M14.8M-8.2M3.7M-25.5M17M27M-75.9M-44.2M28.2M182.4M137.8M142.5M152.4M153.5M137.8M37.86M23.52M10.28M24.7M16.47M1.77M-4.97M-3.05M-2.85M
Minority Interest35.8M53.8M34M36.1M18M14.3M13.1M31.4M8.5M8.1M6.7M6.8M5.8M4.1M3.1M3.4M2.7M1.6M800K538K239K233K193K124K0000

Key Metrics

Growth RegimeDecelerating
ProfitabilityStrained
Balance SheetStrained
Cash FlowMixed
Top Statement Risk

Acquisition-driven leverage expansion

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Balance Sheet Quality Under Pressure

Based on reported financial statements, Bruker's total assets have expanded to $6.1 billion as of 2026Q1, yet the concurrent rise in liabilities and debt suggests that this growth is increasingly funded by external financing rather than organic capital accumulation or retained earnings growth.

The shift in the balance sheet composition indicates a transition toward a more leveraged capital structure. Investors should monitor whether the recent asset expansion translates into improved returns on invested capital or if it merely reflects the integration of capital-intensive acquisitions.

Leverage Metrics Reflect Acquisition Costs

According to recent quarterly filings, Bruker's debt-to-equity ratio reached 0.81 in 2025Q4, a significant increase from the 0.98 level seen in 2023Q4, highlighting the company's reliance on debt financing to support its aggressive inorganic growth strategy in the clinical diagnostics and spatial biology markets.

The elevated debt levels appear to be a direct consequence of recent M&A activity, which may limit the company's financial flexibility in a high-interest-rate environment. This leverage profile warrants further investigation into the sustainability of interest coverage if operating margins remain under pressure.

Goodwill Concentration Risks Asset Quality

As reported in balance sheet data, goodwill has surged to $1.5 billion by 2025Q4, representing a substantial portion of total assets and indicating that a significant share of the company's valuation is tied to intangible assets acquired through recent corporate consolidation efforts.

The heavy reliance on goodwill suggests that the company's asset base is sensitive to impairment risks if the acquired businesses fail to meet performance expectations. This concentration of intangibles may obscure the underlying quality of the physical asset base, which remains focused on specialized manufacturing.

Liquidity Buffers Show Notable Volatility

Based on Bruker's reported figures, the current ratio has fluctuated between 1.55 and 1.85 over the last ten quarters, reflecting inconsistent cash management and the impact of lumpy, project-based revenue recognition on the company's ability to maintain a stable short-term liquidity buffer.

The volatility in liquidity metrics suggests that the company's working capital management is highly sensitive to the timing of large instrument installations. Investors should monitor whether the current cash position of $133.4 million is sufficient to cover operational needs without further reliance on external credit facilities.

Hidden Risks in Capital Allocation

Data from recent filings indicates that the company's retained earnings have remained stagnant at $2.4 billion since 2024Q3, which suggests that recent acquisitions are not yet contributing to meaningful bottom-line growth or the internal generation of capital for future reinvestment.

This stagnation in retained earnings, coupled with rising debt, implies that the company is effectively trading balance sheet strength for potential future growth. This strategy may be perceived as risky if the integration of recent acquisitions does not yield the expected operational synergies.

BRKR — Frequently Asked Questions

Quick answers to the most common questions about buying BRKR stock.

What are the total assets of Bruker Corporation (BRKR)?

As of 2025, Bruker Corporation (BRKR) had total assets of $6.24B including $2.21B in current assets.

How much debt does Bruker Corporation (BRKR) have?

Bruker Corporation (BRKR) carries total debt of $2.04B, offset by $298.8M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Bruker Corporation?

Bruker Corporation (BRKR) has total shareholders' equity (book value) of $2.46B ($16.54 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Bruker Corporation's current ratio and liquidity?

Bruker Corporation (BRKR) reported a current ratio of 1.73x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.